Western blots of total cell extracts from the indicated strains show equal protein levels of Mgs1 and Mgs1* at native levels (left) and when overexpressed (right). Proteins were detected by means of a 9myc-epitope appended to the open reading frame. Antiphosphoglycerate kinase (PGK) blots served as loading control.
analysed in the two-hybrid system using fusions to the Gal4 activation (AD) and DNAbinding (BD) domains as described in Figure 3A , but reversing AD and BD fusions.
(B) Anti-GST blot as control for Figure 3B . The asterisk indicates degradation products.
(C) Interactions of Mgs1 with polyubiquitin chains were analysed in vitro. GST-tagged versions of Mgs1 and Mgs1* or the corresponding UBZ domains only (amino acids 1-47) were immobilised on glutathione Sepharose and assayed for binding to purified Ub 2-7 of K48-or K63-linkage.
3 Figure S3 . PCNA ubiquitylation and effects of Mgs1 in DNA polymerase mutants (A) PCNA undergoes damage-independent ubiquitylation in polymerase mutants. PCNA modification was assessed by denaturing Ni-NTA chromatography and Western blotting as described in Figure 2C in the indicated strains harboring the His POL30 allele.
(B) Deletion of MGS1 or inactivation of its UBZ domain has no effect on the temperature or DNA damage sensitivity of a pol2-11 mutant. MMS and temperature sensitivities were determined by spot assays in the indicated strains. Two colonies each were analysed for strains complemented with integrative vectors.
(C) Deletion of MGS1 or inactivation of its UBZ domain has no effect on the DNA damage sensitivity of a TLS-deficient mutant. MMS sensitivities were determined as in panel B.
4 Figure S4 . Effects of MGS1 overexpression on interactions of PCNA with polymerase η Three-hybrid experiments were carried out as described in Figure 6 , but using Rad30
(polymerase η) as a fusion to the Gal4 DNA-binding domain. 
